A Novel off-the-Shelf Trastuzumab-Armed NK Cell Therapy (ACE1702) Using Antibody-Cell-Conjugation Technology

SIMPLE SUMMARY: Chimeric antigen receptor T cell therapy has shown its potency against hematologic malignancies in autologous settings but also limited success against solid tumors with severe adverse events, including fatal cases of cytokine releasing syndrome. The aim of this research is to develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hao-Kang, Hsiao, Ching-Wen, Yang, Sen-Han, Yang, Hsiu-Ping, Wu, Tai-Sheng, Lee, Chia-Yun, Lin, Yan-Liang, Pan, Janet, Cheng, Zih-Fei, Lai, Yan-Da, Hsiao, Shih-Chia, Tang, Sai-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199224/
https://www.ncbi.nlm.nih.gov/pubmed/34072864
http://dx.doi.org/10.3390/cancers13112724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199224/
https://www.ncbi.nlm.nih.gov/pubmed/34072864
http://dx.doi.org/10.3390/cancers13112724

Ejemplares similares